Table 3. The biological activity spectrum prediction in the « Pharmacological Effects » category at the cutoff value of Pa – Pi > 0.5 for Finerenone. DBMET03393 and DBMET03398 – are Finerenone’s metabolites

Pa

Pi

Биологическая активностьь

Идентификатор соединения

Pa-Pi

0.642

0.005

Myocardial infarction treatment

DB16165

0.637

0.62

0.001

Antihyperaldosteronism

DB16165

0.619

0.592

0.005

Heart failure treatment

DB16165

0.587

0.581

0.004

Liver cirrhosis treatment

DB16165

0.577

0.538

0.012

Cardiotonic

DB16165

0.526

0.629

0.005

Myocardial infarction treatment

DBMET03393

0.624

0.57

0.006

Heart failure treatment

DBMET03393

0.564

0.559

0.004

Liver cirrhosis treatment

DBMET03393

0.555

0.571

0.009

Urologic disorders treatment

DBMET03394

0.562

0.595

0.005

Myocardial infarction treatment

DBMET03398

0.59

0.556

0.007

Heart failure treatment

DBMET03398

0.549

0.527

0.017

Antiischemic

DBMET03398

0.51

0.522

0.019

Hepatic disorders treatment

DBMET03398

0.503